Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Analytical Method Development V 2.0

Analytical Method Development: Preparation of Reagents and Volumetric Solutions – V 2.0

Posted on By

This SOP describes the procedure for preparation, labeling, standardization (where applicable), documentation, and storage of reagents and volumetric solutions used in the Analytical Method Development (AMD) laboratory. It ensures accuracy, consistency, and compliance with GMP and regulatory requirements.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: pH Method Development for API – V 2.0

Posted on By

This SOP defines the procedure for developing and validating pH measurement methods for Active Pharmaceutical Ingredients (APIs) in the Analytical Method Development (AMD) department. It ensures accurate, reproducible, and regulatory-compliant pH determination that supports preformulation, stability, and quality assessment activities.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: pH Method Development for Formulations – V 2.0

Posted on By

This SOP describes the process for developing and validating robust pH measurement methods for pharmaceutical formulations. The procedure ensures accurate and reproducible pH readings that reflect formulation stability, performance, and regulatory expectations.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Titrimetric Assay Development for Acidity – V 2.0

Posted on By

This SOP describes the procedure for developing, optimizing, and validating titrimetric methods for the quantification of acidity in pharmaceutical APIs and formulations. The goal is to ensure accurate, reproducible, and GMP-compliant acidity measurements aligned with pharmacopeial and regulatory requirements.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Titrimetric Assay Development for Alkalinity – V 2.0

Posted on By

This SOP outlines the systematic approach to developing and validating titrimetric methods for determining alkalinity in APIs, excipients, and pharmaceutical formulations. The procedure ensures accurate, repeatable, and compliant results consistent with pharmacopeial standards.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Loss on Drying (LOD) Method Development – V 2.0

Posted on By

This SOP describes the procedure for developing, optimizing, and validating methods to determine Loss on Drying (LOD) for Active Pharmaceutical Ingredients (APIs), excipients, and finished pharmaceutical products. It ensures compliance with regulatory guidelines and accurate assessment of moisture content or volatile impurities.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Water Content Method Development (Karl Fischer) – V 2.0

Posted on By

This SOP outlines the standardized procedure for the development and validation of methods to determine water content using Karl Fischer (KF) titration in the Analytical Method Development (AMD) department. The method ensures accuracy, specificity, and compliance with pharmacopeial standards.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Residue on Ignition / Sulphated Ash Method Development – V 2.0

Posted on By

This SOP defines the procedure for developing and validating methods to determine inorganic residues (non-volatile matter) present in pharmaceutical substances and excipients using Residue on Ignition (ROI) or Sulphated Ash techniques. The goal is to ensure accuracy, reproducibility, and regulatory compliance.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Total Ash and Acid Insoluble Ash Method Development – V 2.0

Posted on By

This SOP defines the procedure for developing and validating analytical methods for the determination of Total Ash and Acid Insoluble Ash in APIs, excipients, and pharmaceutical formulations using ignition and hydrochloric acid treatment, as per pharmacopeial specifications.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Heavy Metals Test Method Development – V 2.0

Posted on By

This SOP defines the procedure for developing, optimizing, and validating analytical methods for the detection and quantification of heavy metals in Active Pharmaceutical Ingredients (APIs), excipients, and finished pharmaceutical products using techniques such as ICP-MS, AAS, or colorimetric wet chemistry.
Click to read the full article.

Analytical Method Development V 2.0

Posts pagination

Previous 1 … 4 5 6 … 38 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme